Supplemental Figures Figure S1 (relates to Figure 1). Distribution of Ta and Tbx16 peaks overlapping histone marks relative to the nearest TSS ±100kb.
(A-C) Graphs indicating the distribution of Ta/Tbx16 common and distinct peaks at each combination of histone marks as defined in Figure 1H . Though nearest TSS ±100kb were annotated the majority of peaks are markedly closer. As expected, Ta and Tbx16 ChIP-seq peaks overlapping H3K4me3 (putative promoters) tend to occur in close proximity to TSSs, while those overlapping H3K4me1 (putative enhancers) are more distant. Note the lower proportion of genes marked by a single factor, compared with ChIP-seq peaks unique to a single factor. This is due to many genes displaying binding for multiple factors at different CRMs. (B) Anatomical enrichment analysis of total genes bound by each factor (nearest TSS ±100kb), or of genes bound by only each individual factor. Analysis was performed relative to anatomical expression patterns recorded in the ZFIN database using DAVID. The reported terms are for cell types/tissues where the factors are reported to be expressed, or which are known to be directly altered in loss-of-function mutants. 1-3 and 6-7) . Summary of reads and mapping statistics for Ta, Tbx16 and Mixl1 ChIP-seq experiments.
Supplemental Data
Data S1. Ta and Tbx16 ChIP-seq coordinates. The nearest TSS ±100kb of each peak and associated gene descriptions and distance from the peak are provided, as well as whether each peak overlaps H3K4me1, H3K4me3 and H3K27ac ChIP-seq peaks from the Bogdanovic et al. (2012) dataset (relates to Figure 1 ). Figure 2 ).
Data S2. Anatomical and functional annotation analysis of genes marked by common and distinct Ta and Tbx16 peaks (relates to

Data S3. Overlap of Ta and Tbx16
ChIP-seq peaks with Eomesa ChIP-seq peaks, plus Mixl1 ChIP-seq peak overlaps with Eomesa and Smad2 ChIP-seq peaks (relates to Figures 3 and 6) . The nearest TSS ±100kb of each peak and associated gene descriptions are provided.
Data S4.
Microarray data analysis of wild type vs. ta;tbx16 double morphants at 90% epiboly (9 h.p.f.; relates to Figure 4 ). Data S5. Anatomical annotation analysis of genes marked by Mixl1 ChIP-seq peaks overlapping Smad2 and/or Eomesa ChIP-seq peaks (relates to Figure 6 ). Also anatomical and functional annotation analysis of genes marked by Mixl1, Nanog, Mxtx2 and/or Pou5f3 related to Figure S5 -6. Data S6. Microarray data analysis of wild type vs. ta;tbx16 double morphants at shield stage (6 h.p.f.), and list of 20 genes from leading edge analysis highlighted in Figure 6H . Data S7. Tables of genomic coordinates occupied by two or more of Eomesa, Mixl1, Mxtx2, Nanog, Pou5f3 and Smad2 (relates to Figure 7) . The nearest TSS ±100kb of each peak and associated gene descriptions are provided.
Supplemental Experimental Procedures
RNA extraction, cDNA synthesis and qRT-PCR Extraction of RNA, synthesis of cDNA and qPCR was performed as reported previously (Cutty et al., 2012) . The primers used for qRT-PCR analysis are listed below:
ChIP-qPCR analysis ChIP-qPCR was performed on approximately 300 to 500 embryos at the indicated stages using 1ul anti-Mixl1 antibody (Anaspec 55613, lot number JI1505), 3ul anti-Ta antibody, 3ul anti-Tbx16 antibody, 3ul anti-Eomesa antibody, 0.5ug anti-Smad2 antibody (clone 31H15L4; Thermo Fisher Scientific) and normal rabbit IgG as described (Garnett et al., 2009; Jahangiri et al., 2012; Morley et al., 2009; Nelson et al., 2014) . qPCR was carried out on a Mx3005P (Agilent Technologies, Santa Clara, CA, USA) using SYBR Green Whole-mount immunostaining and in situ hybridization Embryos fixed in 4% PFA were washed (wash buffer: Phosphate Buffered Saline (PBS);1%DMSO; 0.1%Triton X-100), blocked (2% goat serum;1% Bovine Serum Albumin (BSA) in wash buffer) for 1 hour at room temperature, rewashed and incubated with mouse monoclonal anti-GFP 3E6 IgG2a in wash buffer (A11120, Molecular Probes, 1:300 in block) overnight at 4 o C. Embryos were rewashed, reblocked and incubated with Goat anti-mouse HRP-conjugate in wash buffer (Thermo Scientific diluted to 1µg/ml in block) for four hours at room temperature. Embryos were rewashed, developed using HistoGreen (Linaris) according to the manufacturer's instructions, rewashed, processed through a glycerol gradient and imaged on a Leica MZ16F dissecting microscope. 24 h.p.f. were permeabilized with ice cold acetone for 7 minutes at -20 o C prior to primary antibody incubation.
In situ hybridization was performed as described (Jowett and Lettice, 1994) . Dioxygenin-labelled RNA probes for sox32 , sox17 , foxa3 (Odenthal and Nusslein-Volhard, 1998) , ins (Milewski et al., 1998) and cp (Korzh et al., 2001 ) were produced as previously described.
Cell counting
Photographs of each embryo were taken from a dorsal perspective and using PowerPoint, sharpness was increased to 100% on each photograph to enhance contrast between stained cells and background. A grid was overlaid to ensure the orientation of the embryo was the same in each photograph, with the embryonic midline central on the grid and the dorsal forerunner cells located in the bottom central square, and the cells were manually counted.
Tb morpholino injection 0.5 pmol of tb translation blocking morpholino (GACAGTCACCGGAGTCCATTCTATC; Martin and Kimelman, 2008) was injected with 0.25 pmol of the p53 translation blocking morpholino (GCGCCATTGCTTTGCAAGAATTG; Langheinrich et al., 2002) into one-cell stage embryos.
In vitro protein production and Western blot analyses
Mixl1 expression constructs were pCS2+ mixl1, pCS2+ mix1HA and pCS2+ Eomesodermin. Plasmids were linearized using NotI. Linearized constructs were transcribed with SP6 polymerase to generate capped mRNA according to standard protocols. Capped mRNA for each protein was used to synthesize protein in rabbit reticulocyte lysate according to manufacturer's instructions (Promega). Reticulocyte lysates were subjected to SDS/PAGE on a 10% gel, then blotted to PVDF membrane (GE Healthcare) according to standard protocols. Membranes were blocked for 1 hour at room temperature in 5% skimmed milk powder in Tris buffered saline/0.1% Tween 20 (TBST), then incubated for 16 hours at 4 o C in antibodies diluted in block as indicated in Figure S2 . Blots were then washed extensively in TBST, incubated for 1 hour in either anti-rat or anti-rabbit HRPconjugated antibodies (GE Healthcare), washed extensively in TBST before detection with Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare).
Immunoprecipitation 1µl of in vitro translated Mixl1HA protein was incubated for 16 hours with 1µg of anti-Mixl1 rabbit polyclonal antibody (Anaspec 55613, lot number JI1505) and 15µl BSA-blocked Dynabeads Protein G (ThermoFisher) at 4 o C followed by extensive washing with RIPA buffer. Dynabeads were then boiled in 1x SDS sample buffer and eluate subjected to anti-HA Western blot analysis.
